Nuwellis Inc vs Invesco WilderHill Clean Energy ETF — how do they compare? Nuwellis Inc trades at $2.84 (market cap $1.09M), while Invesco WilderHill Clean Energy ETF trades at $33.9. The key difference: Invesco WilderHill Clean Energy ETF is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| NUWE | PBW | |
|---|---|---|
Market Cap | $1.09M | — |
Sector | Technology | Sector/Thematic |
52-Week High | $527.46 | $46.99 |
52-Week Low | $2.80 | $22.23 |
Enterprise Value | -$722.58K | — |
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $3.00, up 5.26% today, following a 35:1 reverse stock split effective June 26, 2026. The company shows a low P/E of 0.06 and P/S of 0.01, but fundamentals are weak with a -217.22% net income margin and negative ROE. Recent news highlights patent awards and pediatric market expansion, yet cash flow remains negative. Analyst coverage is limited with a split buy/hold consensus.
Outlook is speculative; growth depends on successful commercialization of Aquadex therapy and cost management. Key risks include persistent losses, high cash burn, and competitive pressures. Investors should weigh low valuation against execution risks in the medical technology sector.
PBW trades at $33.21, down 0.54% today, with a bearish technical signal from moving averages and oscillators showing neutral momentum. The ETF faces volatility tied to interest rate cycles, with recent news highlighting clean energy sector tailwinds from energy security concerns and data center demand. Key financial ratios are unavailable, limiting fundamental assessment.
Outlook hinges on clean energy policy support and interest rate sensitivity, with risks including sector volatility and competitive ETF performance. The bearish technical stance and rate-driven sell-offs underscore caution, though long-term energy transition trends offer potential upside.
Trailing returns across standard periods
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →PBW is an equal-weighted ETF that invests in U.S. companies leading the clean energy transition. It focuses on renewable energy, power conservation, and sustainable technologies like solar, wind, and energy storage.
Read more on PBW →